Atea Pharmaceuticals
AVIR
AVIR
118 hedge funds and large institutions have $171M invested in Atea Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 44 increasing their positions, 41 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
11% less funds holding
Funds holding: 132 → 118 (-14)
20% less capital invested
Capital invested by funds: $213M → $171M (-$42.7M)
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Holders
118
Holding in Top 10
2
Calls
$260K
Puts
$78K
Top Buyers
| 1 | +$7.69M | |
| 2 | +$2.9M | |
| 3 | +$1.72M | |
| 4 |
BlackRock
New York
|
+$1.45M |
| 5 |
NM
Newtyn Management
New York
|
+$932K |
Top Sellers
| 1 | -$6.13M | |
| 2 | -$5.79M | |
| 3 | -$2.69M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$761K |
| 5 |
Morgan Stanley
New York
|
-$493K |